scholarly journals Playing the Harmonica with Chronic Obstructive Pulmonary Disease. A qualitative study

2021 ◽  
Author(s):  
A Lewis ◽  
J Conway ◽  
J Middleton ◽  
C Startup ◽  
J Wyatt
Keyword(s):  
Chronic Obstructive Pulmonary Disease ◽  
Pulmonary Disease ◽  
Respiratory Disease ◽  
Thematic Analysis ◽  
Patient Experiences ◽  
Chronic Obstructive ◽  
Standard Group ◽  
Long Term Conditions ◽  
Obstructive Pulmonary Disease ◽  
Breathing Control

AbstractIntroductionPulmonary Rehabilitation (PR) is the gold standard, group-based intervention for individuals with Chronic Obstructive Pulmonary Disease (COPD). However, accessibility and adherence to PR is sub-optimal. Arts in Health interventions also improve health outcomes for people living with long term conditions. Playing the harmonica with COPD could be clinically beneficial. However, little is known about the patient experiences of playing the harmonica.MethodsA qualitative, interpretivist, phenomenological study was undertaken, exploring COPD patient experiences of harmonica playing with a group of others living with chronic respiratory disease. Semi-structured interviews were completed, transcribed, and reflexive inductive thematic analysis performed.ResultsEight people with COPD were interviewed. Thematic analysis generated five themes. Themes included “Hard in the beginning”, “Holding the condition”, “Breathing control”, “Gives you a high” and “Needing the Zoom class”. Playing the harmonica with COPD is difficult at first, particularly drawing a breath through the harmonica. With practice, experience in a fun activity, and quality teaching, individuals were able to become more attuned and embodied with their breathing. As breathing became easier the songs, rather than breathing, became the focus, and participants were able to escape living with respiratory disease when playing. The group was a priority in the weekly lives of participants, even though the buzz of being part of a group was lost.DiscussionPlaying the harmonica requires a different way of breathing and offers a breathing control strategy. Participants also reported the harmonica helped airway clearance and enabled a continued, regular social interaction through COVID-19. The results of this study compliment previous quantitative results and are relevant to physiotherapy. Further mechanistic studies and randomised controlled trials are needed to investigate the biopsychosocial benefits of playing the harmonica with COPD.

Respiratory medicine

2014 ◽  
pp. 293-340
Author(s):  
Chantal Simon ◽  
Hazel Everitt ◽  
Françoise van Dorp ◽  
Matt Burkes
Keyword(s):  
Lung Cancer ◽  
Chronic Obstructive Pulmonary Disease ◽  
Drug Treatment ◽  
Pulmonary Disease ◽  
Respiratory Disease ◽  
Asthma Management ◽  
Respiratory Medicine ◽  
Chronic Obstructive ◽  
Obstructive Pulmonary Disease ◽  
Acute Exacerbations

Breathlessness Cough Chest signs Other signs of respiratory disease Respiratory investigations Bronchodilators and steroids Asthma in adults Asthma management in practice Drug treatment of asthma Chronic obstructive pulmonary disease Management of COPD Acute exacerbations of COPD Lung cancer Colds and influenza Pneumonia in adults Tuberculosis...

scholarly journals Advances in Pharmacological Actions and Mechanisms of Flavonoids from Traditional Chinese Medicine in Treating Chronic Obstructive Pulmonary Disease

2020 ◽  
Vol 2020 ◽  
pp. 1-10
Author(s):  
Yang Yang ◽  
Xin Jin ◽  
Xinyi Jiao ◽  
Jinjing Li ◽  
Liuyi Liang ◽  
...  
Keyword(s):  
Chronic Obstructive Pulmonary Disease ◽  
Chinese Medicine ◽  
Traditional Chinese Medicine ◽  
Pulmonary Disease ◽  
Respiratory Disease ◽  
Chronic Obstructive ◽  
Pharmacokinetic Studies ◽  
High Morbidity ◽  
External Application ◽  
Obstructive Pulmonary Disease

Chronic obstructive pulmonary disease (COPD) is a common respiratory disease with high morbidity and mortality. The conventional therapies remain palliative and have various undesired effects. Flavonoids from traditional Chinese medicine (TCM) have been proved to exert protective effects on COPD. This review aims to illuminate the poly-pharmacological properties of flavonoids in treating COPD based on laboratory evidences and clinical data and points out possible molecular mechanisms. Animal/laboratory studies and randomised clinical trials about administration of flavonoids from TCM for treating COPD from January 2010 to October 2020 were identified and collected, with the following terms: chronic obstructive pulmonary disease or chronic respiratory disease or inflammatory lung disease, and flavonoid or nature product or traditional Chinese medicine. Pharmacokinetic studies and external application treatment were excluded. A total of 15 flavonoid compounds were listed. Flavonoids could inhibit inflammation, oxidative stress, and cellular senescence, restore corticosteroid sensitivity, improve pulmonary histology, and boost pulmonary function through regulating multiple targets and signaling pathways, which manifest that flavonoids are a group of promising natural products for COPD. Nevertheless, most studies remain in the research phase of animal testing, and further clinical applications should be carried out.

Sequelae of Childhood Respiratory Disease

1981 ◽  
Vol 2 (7) ◽  
pp. 196-212
Keyword(s):  
Chronic Obstructive Pulmonary Disease ◽  
Air Pollution ◽  
Pulmonary Function ◽  
Airway Obstruction ◽  
Pulmonary Disease ◽  
Respiratory Disease ◽  
Chronic Obstructive ◽  
Elastic Recoil ◽  
Obstructive Pulmonary Disease ◽  
Small Airway Obstruction

Gurwitz and associates studied 17 children a decade after acute hydrocarbon pneumonitis at mean age 18 months. Eighty-two percent had pulmonary function abnormalities usually on the basis of either small airway obstruction and/or loss of elastic recoil. None of the children smoked but the pathophysiologic changes seen were similar to those of smokers. These children may be especially susceptible to the additional insults of smoking and air pollution. Comment: The implications of these studies are profound. Childhood respiratory insults may be much more significant than previously believed. Subsequent additional insults such as smoking may tip the balance toward chronic obstructive pulmonary disease.

Circulating miRNAs as diagnostic tool for discrimination of respiratory disease: Asthma, asthma‐chronic obstructive pulmonary disease (COPD) overlap and COPD

Allergy ◽  
2019 ◽  
Vol 74 (12) ◽  
pp. 2491-2494 ◽  
Author(s):  
Jose M. Rodrigo‐Muñoz ◽  
Manuel J. Rial ◽  
Beatriz Sastre ◽  
Jose A. Cañas ◽  
Ignacio Mahíllo‐Fernández ◽  
...  
Keyword(s):  
Chronic Obstructive Pulmonary Disease ◽  
Pulmonary Disease ◽  
Respiratory Disease ◽  
Diagnostic Tool ◽  
Chronic Obstructive ◽  
Circulating Mirnas ◽  
Obstructive Pulmonary Disease

scholarly journals Mortality among Subjects with Chronic Obstructive Pulmonary Disease or Asthma at Two Respiratory Disease Clinics in Ontario

2011 ◽  
Vol 18 (6) ◽  
pp. 327-332 ◽  
Author(s):  
Murray M Finkelstein ◽  
Kenneth R Chapman ◽  
R Andrew McIvor ◽  
Malcolm R Sears
Keyword(s):  
Risk Factors ◽  
Chronic Obstructive Pulmonary Disease ◽  
Pulmonary Disease ◽  
Respiratory Disease ◽  
Mortality Rates ◽  
Chronic Obstructive ◽  
Obstructive Pulmonary Disease ◽  
Risk Of Death ◽  
Severity Scores ◽  
Standardized Mortality Ratios

BACKGROUND: Chronic obstructive pulmonary disease (COPD) and asthma are common; however, mortality rates among individuals with these diseases are not well studied in North America.OBJECTIVE: To investigate mortality rates and risk factors for premature death among subjects with COPD.METHODS: Subjects were identified from the lung function testing databases of two academic respiratory disease clinics in Hamilton and Toronto, Ontario. Mortality was ascertained by linkage to the Ontario mortality registry between 1992 and 2002, inclusive. Standardized mortality ratios were computed. Poisson regression of standardized mortality ratios and proportional hazards regression were performed to examine the multivariate effect of risk factors on the standardized mortality ratios and mortality hazards.RESULTS: Compared with the Ontario population, all-cause mortality was approximately doubled among subjects with COPD, but was lower than expected among subjects with asthma. The risk of mortality in patients with COPD was related to cigarette smoking, to the presence of comorbid conditons of ischemic heart disease and diabetes, and to Global initiative for chronic Obstructive Lung Disease severity scores. Individuals living closer to traffic sources showed an elevated risk of death compared with those who lived further away from traffic sources.CONCLUSIONS: Mortality rates among subjects diagnosed with COPD were substantially elevated. There were several deaths attributed to asthma among subjects in the present study; however, overall, patients with asthma demonstrated lower mortality rates than the general population. Subjects with COPD need to be managed with attention devoted to both their respiratory disorders and related comorbidities.

Sign in / Sign up

Export Citation Format

Share Document